Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial
Francesco Di Pierro, Somia Iqtadar, Amjad Khan, et al.
International Journal of General Medicine (2021) Vol. Volume 14, pp. 2807-2816
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Senescence and cancer — role and therapeutic opportunities
Clemens A. Schmitt, Boshi Wang, Marco Demaria
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 10, pp. 619-636
Open Access | Times Cited: 400
Virus-induced senescence is a driver and therapeutic target in COVID-19
Soyoung Lee, Yong Yu, Jakob Trimpert, et al.
Nature (2021) Vol. 599, Iss. 7884, pp. 283-289
Open Access | Times Cited: 268
Antimicrobial Activity of Quercetin: An Approach to Its Mechanistic Principle
Thi Lan Anh Nguyen, Debanjana Bhattacharya
Molecules (2022) Vol. 27, Iss. 8, pp. 2494-2494
Open Access | Times Cited: 257
A single-cell transcriptomic landscape of the lungs of patients with COVID-19
Si Wang, Xiaohong Yao, Shuai Ma, et al.
Nature Cell Biology (2021) Vol. 23, Iss. 12, pp. 1314-1328
Open Access | Times Cited: 158
COVID-19 and cellular senescence
Clemens A. Schmitt, Tamar Tchkonia, Laura J. Niedernhofer, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 4, pp. 251-263
Open Access | Times Cited: 99
Biosynthesis Investigations of Terpenoid, Alkaloid, and Flavonoid Antimicrobial Agents Derived from Medicinal Plants
Wenqian Huang, Yingxia Wang, Weisheng Tian, et al.
Antibiotics (2022) Vol. 11, Iss. 10, pp. 1380-1380
Open Access | Times Cited: 75
The impact of the COVID-19 pandemic on lifestyle behaviors in children and adolescents: an international overview
Serena Scapaticci, Costanza Neri, Gian Luigi Marseglia, et al.
˜The œItalian Journal of Pediatrics/Italian journal of pediatrics (2022) Vol. 48, Iss. 1
Open Access | Times Cited: 74
Pulmonary infection by SARS-CoV-2 induces senescence accompanied by an inflammatory phenotype in severe COVID-19: possible implications for viral mutagenesis
Konstantinos Evangelou, Dimitris Veroutis, Koralia Paschalaki, et al.
European Respiratory Journal (2022) Vol. 60, Iss. 2, pp. 2102951-2102951
Open Access | Times Cited: 70
Flavonoids: A treasure house of prospective pharmacological potentials
Hasin Hasnat, Suriya Akter Shompa, Mirazul Islam, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27533-e27533
Open Access | Times Cited: 53
Quercetin as a Therapeutic Product: Evaluation of Its Pharmacological Action and Clinical Applications—A Review
Mohd. Aamir Mirza, Syed Mahmood, Ayah Rebhi Hilles, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1631-1631
Open Access | Times Cited: 48
The Role of Quercetin, a Flavonoid in the Management of Pathogenesis Through Regulation of Oxidative Stress, Inflammation, and Biological Activities
Hajed O. Alharbi, Mohammad Alshebremi, Ali Yousif Babiker, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 151-151
Open Access | Times Cited: 1
Potential pharmacological effect of Quercetin Phytosome™ in the management of hyperuricemia: results from real-life clinical studies
Francesco Di Pierro, Fazle Rabbani, Muhammad Burhan Khan Tareen, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access | Times Cited: 1
The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: A randomized controlled trial
Mojtaba Shohan, Roohangiz Nashibi, Mohammad‐Reza Mahmoudian‐Sani, et al.
European Journal of Pharmacology (2021) Vol. 914, pp. 174615-174615
Open Access | Times Cited: 86
Pharmacological Activity of Quercetin: An Updated Review
Guanzhen Wang, Yuanhui Wang, Liangliang Yao, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 65
The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature
Mohd Imran, Hamdy Khamees Thabet, Saleh I. Alaqel, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 876-876
Open Access | Times Cited: 62
Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease
Seodhna M. Lynch, Guangran Guo, David S. Gibson, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3367-3367
Open Access | Times Cited: 60
Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: Potential role in prevention and management of COVID-19
Souparnika H. Manjunath, Rajesh K. Thimmulappa
Journal of Pharmaceutical Analysis (2021) Vol. 12, Iss. 1, pp. 29-34
Open Access | Times Cited: 57
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 56
Honey and Nigella sativa against COVID‐19 in Pakistan (HNS‐COVID‐PK): A multicenter placebo‐controlled randomized clinical trial
Sohaib Ashraf, Shoaib Ashraf, Moneeb Ashraf, et al.
Phytotherapy Research (2022) Vol. 37, Iss. 2, pp. 627-644
Closed Access | Times Cited: 41
Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial
Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 38
Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial
Francesco Di Pierro, Amjad Khan, Somia Iqtadar, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 32
Removal of senescent cells reduces the viral load and attenuates pulmonary and systemic inflammation in SARS-CoV-2-infected, aged hamsters
Lou Delval, Aline Hantute-Ghesquier, Valentin Sencio, et al.
Nature Aging (2023) Vol. 3, Iss. 7, pp. 829-845
Open Access | Times Cited: 25
New opportunities and advances in quercetin-added functional packaging films for sustainable packaging applications: a mini-review
Swarup Roy, Parya Ezati, Ajahar Khan, et al.
Critical Reviews in Food Science and Nutrition (2023) Vol. 64, Iss. 23, pp. 8464-8479
Closed Access | Times Cited: 24
Quercetin for the treatment of COVID‐19 patients: A systematic review and meta‐analysis
Huzaifa Ahmad Cheema, Aruba Sohail, Areej Fatima, et al.
Reviews in Medical Virology (2023) Vol. 33, Iss. 2
Closed Access | Times Cited: 23
Inflammation, Mitochondria and Natural Compounds Together in the Circle of Trust
Salvatore Nesci, Anna Spagnoletta, Francesca Oppedisano
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6106-6106
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top